Global Clinical Laboratory Tests Market

Clinical Laboratory Tests Market Size, Share, Growth Analysis, By Type(Complete Blood Count, Basic Metabolic Panel Testing, HGB/ HCT testing, Comprehensive Metabolic Panel Testing), By End Use(Central Laboratories (Complete Blood Count, HGB/ HCT testing, Basic Metabolic Panel Testing, BUN Creatinine Testing), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2276 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 70 |Figures: 75

Clinical Laboratory Tests Market Insights

Clinical Laboratory Tests Market size was valued at USD 94.76 Billion in 2021 and is poised to grow from USD 103.67 billion in 2022 to USD 212.71 billion by 2030, growing at a CAGR of 9.4% during the forecast period (2023-2030).

The market for clinical laboratories is growing as a result of the aging of the population, the rise of target illness cases, and the development of innovative solutions to meet the market's rising need for clinical testing. The medical and testing sectors have been greatly impacted by COVID-19's ubiquitous availability. Clinical laboratory test demand has been negatively impacted by the pandemic. The widespread availability of COVID-19 has significantly impacted the healthcare and testing industries. The pandemic's negative consequences have been seen in the market for clinical laboratory tests. This is also due to the fact that fewer people underwent routine medical examinations overall during the pandemic, which decreased the amount of clinical chemical tests performed. The number of tests performed has since returned to normal, though, suggesting that the COVID-19 pandemic had no lasting negative effects on the market.

The WHO reports that in the majority of industrialized economies, the average life expectancy has surpassed 80 years. Aging is characterized as a significant risk factor for the emergence of infectious diseases due to the interaction of various genetic and environmental variables that impact immunity and metabolism, changing the function of organs. Therefore, diagnostics and screening might be crucial in the treatment of general health. Therefore, as the elderly population grows, so does the demand for acute & long-term healthcare, fueling the expansion of the global market.

Furthermore, it is anticipated that the development of novel approaches to maximizing effectiveness and minimizing errors would significantly boost the performance of this industry. With businesses processing as much as 100 to 150 billion samples annually, integrated flow management platforms, database management tools, & patient test records are becoming more and more important in the healthcare sector. This market's expansion is anticipated to be fueled by the execution and growth of data management & informatics solutions for aiding efficient operations.

However, the regulatory environment surrounding clinical laboratory tests is unclear, which limits market growth. The U.S. FDA and the European Medicines Agency (EMA), for example, have built regulatory frameworks that are heavily reliant on by the healthcare sector. In emerging nations like China and India, the diagnostic industry is not subject to any clear regulatory standards. Laboratory-developed testing that refers to providing accurate and speedy results and internal clinical laboratories creating tests are subject to FDA regulation. Profit margins may suffer as a result of LDT risks, and the launch of newly developed tests may be delayed.

US Clinical Laboratory Tests Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2023-2030

Global Market Size

USD 94.76 Billion

Largest Segment

Central Laboratories

Fastest Growth

Central Laboratories

Growth Rate

9.4% CAGR

Global Clinical Laboratory Tests Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Clinical Laboratory Tests Market Segmental Analysis

Global Clinical Laboratory Tests Market is segmented by gender transition, procedure, end use, and region. Based on type, the market can be segmented into Complete Blood Count, Basic Metabolic Panel Testing, HGB/ HCT testing, Comprehensive Metabolic Panel Testing, BUN Creatinine Testing, HbA1c Testing, Electrolytes Testing, Liver Panel Testing (Hepatitis, Bile Duct Obstruction, Liver Cirrhosis, Liver Cancer, Bone Disease, Autoimmune Disorders, Others), Lipid Panel Testing, Renal Panel Testing, Cardiovascular Panel Tests. Based on end use, the market is segmented into Central Laboratories (Complete Blood Count, HGB/ HCT testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Renal Panel Testing, Lipid Panel Testing, Cardiovascular Panel Tests), and Primary Clinics (Complete Blood Count, HGB/ HCT testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Renal Panel Testing, Lipid Panel Testing, Cardiovascular Panel Tests). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. 

Clinical Laboratory Tests Market Analysis by Type

In 2022, the HbA1c testing category accounted for the greatest market share. As patients with fluctuating levels of HbA1c run a higher risk of developing problems from diabetes, it is projected that the growing number of patients with diabetes and aberrant cholesterol levels will fuel market expansion. Additionally, the introduction of more recent laboratory testing is anticipated to further fuel market expansion. For instance, OmegaQuant introduced the HbA1c Test in May 2022 to measure the level of blood sugar in the body. A home collecting device for risky diabetes testing called LabCorp on demand was also introduced by LabCorp in May 2022. Such fresh launches provide accessibility to a variety of lab tests for determining blood sugar levels.

The HGB/HCT testing category is likely to grow at the quickest pace over the anticipated time frame. The segment's growth is attributed to the high prevalence of blood-related illnesses in the general population. The test is conducted to ascertain the presence of polycythemia or anemia. Additionally, judgements about blood transfusions, medication responses, and dehydration are made using the HGB/HCT test. The increased prevalence of anemia along with other blood disorders throughout the forecast period is expected to boost market growth, as will the introduction of non-invasive & technologically advanced equipment.

Clinical Laboratory Tests Market Analysis by End-use

In 2022, the primary clinics sector held the biggest market share for clinical laboratory tests. Primary healthcare facilities with their own laboratories, physician clinics with their own laboratories that take samples from doctors directly, clinical research facilities, and insurance firms are examples of primary clinics. The test is easily made available to patients right away, and the care team, doctor, and patients may swiftly acquire the results, enabling them to make clinical management decisions on the spur of the moment. They offer a lesser range of tests than hospitals or independent laboratories. These laboratories only serve a small number of specializations, which results in a minimal income share. Despite their modest contributions, these are anticipated to continue to support market expansion.

The central laboratories industry is likely to grow at the fastest rate during the forecast time frame. The segment's expansion is attributable to its high levels of procedure volume and market penetration. The increasing number of initiatives done by governments to provide different services, such as payment for clinical laboratory testing, is another important driver anticipated to drive the market. Many healthcare companies are working with labs to integrate a variety of tests, including microbiology testing. Additionally, a sizable amount originates from a substantial number of institutions in emerging and developing nations. Regulatory organizations are also making improvements to lab services and streamlining the diagnosis procedure.

Global Clinical Laboratory Tests Market By End-use , 2021 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Clinical Laboratory Tests Market Regional Insights

North America dominated the market in terms of share in 2022, and it is anticipated that it will continue to do so during the forecast period. This might be linked to the region's growing senior population, increased chronic illness prevalence, including cancer, and strong market penetration of cutting-edge diagnostic techniques. One of the primary cause’s deaths in North America, reported to the American Cancer Society as a whole, is cancer. Prostate cancer in males and cancer of the breast in women are the two cancers that are most frequently diagnosed. The regional market is anticipated to be driven by factors like rising patient awareness and growing inclination for novel techniques.

Asia Pacific is expected to experience the fastest growth in the clinical laboratory testing industry over the time of the forecast. The market in the region is developing due to the vast untapped potential represented by unmet medical demands, rising technological horizons, and positive economic growth. Asia Pacific is home to more than one-third of the global population, and this region has been severely struck by the COVID-19 epidemic. Clinical laboratories have gained in importance as a result of their crucial role in carrying out tests. China and India have seen the highest number of SARS-CoV-2 tests. However, it is necessary to increase testing capacity in order to close the gaps in the medical laboratory market.

Global Clinical Laboratory Tests Market By Geography, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Clinical Laboratory Tests Market Dynamics

Clinical Laboratory Tests Market Drivers

Increasing Disease Burden

  • The growing prevalence of chronic diseases and infectious diseases worldwide is driving the demand for clinical laboratory tests. These tests play a crucial role in disease diagnosis, monitoring, and treatment.

Technological Advancements

  • Advances in laboratory testing technologies, such as automation, molecular diagnostics, and point-of-care testing, have improved the accuracy, speed, and efficiency of clinical laboratory tests. These advancements have expanded the scope of testing and facilitated quicker turnaround times for results.

Clinical Laboratory Tests Market Restraints

High Cost

  • Clinical laboratory tests can be expensive, especially for complex or specialized tests. The cost of equipment, reagents, and skilled personnel required for accurate testing can pose a financial burden on patients and healthcare systems.

Stringent Regulatory Requirements

  • Clinical laboratory tests are subject to strict regulations and quality control standards to ensure accuracy and patient safety. Complying with these requirements can increase operational costs and add complexity to the testing process.

Request Free Customization of this report to help us to meet your business objectives.

Clinical Laboratory Tests Market Competitive Landscape

The major players in the clinical laboratory test industry are continually working to improve patient outcomes and the effectiveness and effectiveness of healthcare by introducing new technologies and altering those that already exist. For instance, Omega Laboratories will begin conducting urine tests as part of its new Urine Drugs of Use Testing Services in December 2022, complementing its DNA testing in Canada.

Clinical Laboratory Tests Market Top Player’s Company Profiles

  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings (LabCorp)
  • Siemens Healthineers AG
  • Roche Diagnostics
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • Becton, Dickinson and Company (BD)
  • bioMérieux SA
  • Agilent Technologies, Inc.
  • Genomic Health, Inc.
  • Myriad Genetics, Inc.
  • Cepheid (a subsidiary of Danaher Corporation)
  • QIAGEN N.V.
  • Hologic, Inc.
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • GenMark Diagnostics, Inc.

Clinical Laboratory Tests Market Recent Developments

  • In September 2022, Optical genome mapping (OGM) information services from Bionano Genomics Inc. will be combined with clinical testing services formerly provided by Lineagen at the new company, Bionano Laboratories, that was launched. The first OGM-based laboratory-designed test (LDT), created by Bionano Laboratories, was also introduced.
  • In March 2022, For small-to-midsize labs that use both complete blood count (CBC) & the erythrocyte sedimentation rate (ESR) assays, Mindray recently introduced its newest BC-700 Series hematology analyzers.

Clinical Laboratory Tests Key Market Trends

  • Increasing Demand for Molecular Diagnostics: There is a growing demand for molecular diagnostic tests that can detect genetic variations, infectious diseases, and other biomarkers at the molecular level. Advances in genomics and targeted therapies have led to the integration of molecular diagnostics into routine clinical practice.
  • Point-of-Care Testing (POCT) on the Rise: Point-of-care testing, which enables rapid testing and immediate results at or near the patient's location, is gaining popularity. POCT offers advantages such as faster turnaround time, convenience, and improved patient outcomes, driving its adoption across various healthcare settings.
  • Digitalization and Automation: Laboratories are increasingly adopting digital solutions and automation to streamline laboratory processes, improve efficiency, and enhance accuracy in test results. This includes laboratory information management systems (LIMS), robotics, artificial intelligence (AI), and machine learning (ML) for data analysis and interpretation.
  • Growing Importance of Liquid Biopsies: Liquid biopsy tests, which detect circulating tumor DNA (ctDNA) and other biomarkers in blood samples, are gaining significance in cancer diagnosis, treatment monitoring, and recurrence detection. Liquid biopsies offer non-invasive and real-time monitoring, revolutionizing oncology diagnostics.
  • Expansion of Companion Diagnostics: Companion diagnostics are tests that are developed alongside specific drugs to identify patients who will benefit most from the treatment. The market for companion diagnostics is expanding as personalized medicine becomes more prevalent, enabling targeted therapies and improving treatment outcomes.
  • Integration of Artificial Intelligence and Big Data Analytics: The integration of AI and big data analytics is revolutionizing clinical laboratory testing. These technologies enable pattern recognition, predictive analytics, and decision support systems, enhancing diagnostic accuracy, workflow efficiency, and patient outcomes.

Clinical Laboratory Tests Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our clinical laboratory tests market analysis, the growing prevalence of chronic diseases and infectious diseases worldwide is driving the demand for clinical laboratory tests. These tests play a crucial role in disease diagnosis, monitoring, and treatment. However, Asia Pacific is expected to experience the fastest growth in the clinical laboratory testing industry over the time of the forecast. The market in the region is developing due to the vast untapped potential represented by unmet medical demands, rising technological horizons, and positive economic growth.

Report Metric Details
Market size value in 2021 USD 94.76 Billion
Market size value in 2030 USD 212.71 billion
Growth Rate 9.4%
Base year 2023
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Complete Blood Count, Basic Metabolic Panel Testing, HGB/ HCT testing, Comprehensive Metabolic Panel Testing, BUN Creatinine Testing, HbA1c Testing, Electrolytes Testing, Liver Panel Testing (Hepatitis, Bile Duct Obstruction, Liver Cirrhosis, Liver Cancer, Bone Disease, Autoimmune Disorders, Others), Lipid Panel Testing, Renal Panel Testing, Cardiovascular Panel Tests
  • End Use
    • Central Laboratories (Complete Blood Count, HGB/ HCT testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Renal Panel Testing, Lipid Panel Testing, Cardiovascular Panel Tests), Primary Clinics (Complete Blood Count, HGB/ HCT testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Renal Panel Testing, Lipid Panel Testing, Cardiovascular Panel Tests)
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings (LabCorp)
  • Siemens Healthineers AG
  • Roche Diagnostics
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • Becton, Dickinson and Company (BD)
  • bioMérieux SA
  • Agilent Technologies, Inc.
  • Genomic Health, Inc.
  • Myriad Genetics, Inc.
  • Cepheid (a subsidiary of Danaher Corporation)
  • QIAGEN N.V.
  • Hologic, Inc.
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • GenMark Diagnostics, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Clinical Laboratory Tests Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Clinical Laboratory Tests Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Clinical Laboratory Tests Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Clinical Laboratory Tests Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Clinical Laboratory Tests Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Clinical Laboratory Tests Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Clinical Laboratory Tests Market size was valued at USD 94.76 Billion in 2021 and is poised to grow from USD 103.67 billion in 2022 to USD 212.71 billion by 2030, growing at a CAGR of 9.4% during the forecast period (2023-2030).

The major players in the clinical laboratory test industry are continually working to improve patient outcomes and the effectiveness and effectiveness of healthcare by introducing new technologies and altering those that already exist. For instance, Omega Laboratories will begin conducting urine tests as part of its new Urine Drugs of Use Testing Services in December 2022, complementing its DNA testing in Canada. 'Quest Diagnostics Incorporated', 'Laboratory Corporation of America Holdings (LabCorp)', 'Siemens Healthineers AG', 'Roche Diagnostics', 'Abbott Laboratories', 'Thermo Fisher Scientific Inc.', 'Bio-Rad Laboratories, Inc.', 'Danaher Corporation', 'Sysmex Corporation', 'Becton, Dickinson and Company (BD)', 'bioMérieux SA', 'Agilent Technologies, Inc.', 'Genomic Health, Inc.', 'Myriad Genetics, Inc.', 'Cepheid (a subsidiary of Danaher Corporation)', 'QIAGEN N.V.', 'Hologic, Inc.', 'Ortho Clinical Diagnostics', 'PerkinElmer, Inc.', 'GenMark Diagnostics, Inc.'

The growing prevalence of chronic diseases and infectious diseases worldwide is driving the demand for clinical laboratory tests. These tests play a crucial role in disease diagnosis, monitoring, and treatment.

Increasing Demand for Molecular Diagnostics: There is a growing demand for molecular diagnostic tests that can detect genetic variations, infectious diseases, and other biomarkers at the molecular level. Advances in genomics and targeted therapies have led to the integration of molecular diagnostics into routine clinical practice.

North America dominated the market in terms of share in 2022, and it is anticipated that it will continue to do so during the forecast period. This might be linked to the region's growing senior population, increased chronic illness prevalence, including cancer, and strong market penetration of cutting-edge diagnostic techniques. One of the primary cause’s deaths in North America, reported to the American Cancer Society as a whole, is cancer. Prostate cancer in males and cancer of the breast in women are the two cancers that are most frequently diagnosed. The regional market is anticipated to be driven by factors like rising patient awareness and growing inclination for novel techniques.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Clinical Laboratory Tests Market

Product ID: SQMIG35I2276

$5,300
BUY NOW GET FREE SAMPLE